Teva Pharmaceutical Industries Shareholders Equity:
22.71B for March 31, 2013Teva Pharmaceutical Industries Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 22.71B |
| Dec. 31, 2012 | 22.77B |
| Sept. 30, 2012 | 22.93B |
| June 30, 2012 | 22.75B |
| March 31, 2012 | 23.05B |
| Dec. 31, 2011 | 22.20B |
| Sept. 30, 2011 | 22.86B |
| June 30, 2011 | 23.68B |
| March 31, 2011 | 23.07B |
| Dec. 31, 2010 | 21.95B |
| Sept. 30, 2010 | 21.67B |
| June 30, 2010 | 19.33B |
| March 31, 2010 | 19.65B |
| Dec. 31, 2009 | 19.22B |
| Sept. 30, 2009 | 19.26B |
| June 30, 2009 | 17.82B |
| March 31, 2009 | 16.14B |
| Dec. 31, 2008 | 16.30B |
| Sept. 30, 2008 | 14.84B |
| June 30, 2008 | 15.08B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
TEVA Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Alexza Pharmaceuticals | 2.573M |
| Mylan | 2.871B |
| Akorn | 215.09M |
TEVA Shareholders Equity Rankings
| Overall |
98th percentile 126 of 7590 |
| Sector |
99th percentile 6 of 651 in Healthcare |
| Industry |
98th percentile 1 of 65 in Drug Manufacturers - Specialty & Generic |
TEVA Shareholders Equity Range, Past 5 Years
| Minimum | 14.84B | Sep 2008 |
| Maximum | 23.68B | Jun 2011 |
| Average | 20.36B |